- Home
- Therapeutische gebieden
- Dermatologie
- Oncologie
- Oncologie
- Congressen
- ASCO 2020
- Borstkanker
- Longkanker
- Melanoom
- Van Hollandse Bodem
- De Breast Cancer Index in de behandeling van hormoongevoelige borstkankerpatiënten
- De overleving van ineligible melanoompatienten
- De rol van chirurgie bij patienten met gemtastaseerd melanoom
- HER2-heterogeniteit in adenocarcinomen bij maag- en slokdarmkanker
- Resultaten van het BRCA1/2 gemuteerde DRUP-cohort
- Resultaten van therapeutic drug monitoring (TDM) bij pazopanibbehandeling
- Studie resultaten van 89ZR-durvalumab PD-L1 PET bij hoofdhalstumoren
- Studieresultaten over het waakzaam wachten met behandeling bij pas gediagnosticeerde uitgezaaide clear cell niercelcarcinomen
- Studieresultaten van geslachtsverschillen in tumor- en behandelingskenmerken bij potentieel curabele maag- en slokdarmcarcinomen
- ESMO Breast 2020
- ENETS 2019
- ESMO 2019
- SABCS 2019
- ASCO 2019
- ESMO 2018
- ASCO 2020
- Indicatiegebieden
- Onderzoek
- Ons team
- Congressen
- Oncologie
- Pulmonologie
- Reumatologie
- Hematologie
- Hematalks
- Congressen
- ASH 2019
- A Test to Quantify NOTCH Pathway Activity in T Cell Acute Lymphoblastic Leukemia Patients
- ASH 2019 - Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study
- ASH 2019 - Novel Thermostable Inhibitor of Contact Activation Tica Effectively Blocks Contact Activation in Low Tissue Factor Thrombin Generation
- ASH 2019 - Proteomic Landscape of Acute Leukemia: A Comparison between ALL and AML in Adults
- ASH 2019 - Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in progress
- ASH 2019 Highlight: Myelodysplastisch Syndroom
- ASH 2019: Highlight: acute lymfatische leukemie kinderen
- Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients
- Association of Endothelial Biomarkers with Cerebral MRI Perfusion Analysis in Patients with Sickle Cell Disease
- Baseline Metabolic Tumor Volume in 18FDG-PET-CT Scans in Classical Hodgkin Lymphoma Using Semi-Automatic Segmentation
- Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis
- Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors
- Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study
- Hemolysis in the Spleen Drives Erythrocyte Turnover
- Higher Expression of Nuclear Cereblon in Bone Marrow Biopsies of Patients with Multiple Myeloma Treated with Imids in the HOVON-87/Nmsg-18 Trial Is Associated with Longer PFS and OS
- Inflammatory Bone Marrow Microenvironment
- Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
- MAPK-ERK Pathway Activation: The Achilles’ Heel of IL-7R‒Induced Steroid Resistance
- Minimal Residual Disease and Stem Cell Transplantation OutcomesMinimal Residual Disease and Stem Cell Transplantation Outcomes
- One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment
- Platelet CD34 Expression and a Congenital Collar Bone Malformation Associated with a Partial CBFB Deletion in a Case with a Bleeding Disorder
- Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study
- The First Functional HLA-a*01:01-Restricted EBV-LMP2-Specific T-Cell Receptors for TCR Gene Therapy of Patients with EBV-Associated Type II/III Malignancies
- The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium
- Untargeted Metabolomics on Dried Blood Spots for the Diagnosis and Clinical Follow up of Rare Hereditary Anemias
- Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients Receiving Vincristine through Push Injections or One-Hour Infusions: Results of a Randomized Clinical Trial
- ASH 2018
- ASH 2017
- ASH archief
- EHA 2019
- Coagulation, hematopoiesis and tumorigenesis
- EHA 2019 - Dr. Marije Bartels
- EHA 2019 - Drs. Julia Driessen
- EHA 2019 - Prof. dr. Daphne de Jong
- EHA-ESMO Joint Symposium: Magnitude of Clinical Benefit Scale (MCBS)
- Impact of the new EU regulations for in Vitro Diagnostics (IVDR)
- Is it of vital importance to identify BCR-ABL-like ALL?
- Molecular minimal residual disease detection in acute myeloid leukemia
- Prof. Dr. A. van de Loosdrecht
- EHA 2018
- EHA 2017
- EHA archief
- Nationaal Congres
- International Congress Other
- ASH
- ASH 2019
- Indicatiegebieden
- Congressen
- Hematalks
- Neurologie
- Oogheelkunde
- Cardiologie
- Producten
- Nascholingen & Events
- Webshop
- Contact
×
Ask Speakers
×